Robert P. Perrillo
Baylor University Medical Center · 154 works · 13,252 citations · h-index 48
Top works
- Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa
- Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection
- A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B
- Pathological diagnosis of chronic hepatitis C: A multicenter comparative study with chronic hepatitis B
- Association of Diabetes Mellitus and Chronic Hepatitis C Virus Infection
- Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients.
- Application of Six Hepatitis C Virus Genotyping Systems to Sera from Chronic Hepatitis C Patients in the United States
- Prednisone Withdrawal Followed by Recombinant Alpha Interferon in the Treatment of Chronic Type B Hepatitis
- Spontaneous Clearance and Reactivation of Hepatitis B Virus Infection Among Male Homosexuals with Chronic Type B Hepatitis
- Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: Definition of optimal conditions for specimen collection and clinical application in interferon-treated patients
- Acute flares in chronic hepatitis B: The natural and unnatural history of an immunologically mediated liver disease
- Chronic Hepatitis B in Asymptomatic Homosexual Men with Antibody to the Human Immunodeficiency Virus
- A Multicenter United States—Canadian Trial to Assess Lamivudine Monotherapy Before and After Liver Transplantation for Chronic Hepatitis B
- Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
- The role of liver biopsy in hepatitis C
- Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus
- Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile.
- Response to Higher Doses of Interferon Alfa–2B in Patients With Chronic Hepatitis C: A Randomized Multicenter Trial
- Long–Term Mortality and Morbidity of Transfusion–Associated Non–A, Non–B, and Type C Hepatitis: A National Heart, Lung, and Blood Institute Collaborative Study